Cellular Biomedicine Group Announces $30.6M Investment From Sailing Capital Overseas Investment Feb 5, 2018 Life Science
Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma Feb 2, 2018 Life Science
Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX (neratinib) in Greater China Feb 2, 2018 Life Science
Vitargent Forms Strategic Alliance With PwC to Accelerate Product Safety Testing Technologies in China, Hong Kong and Southeast Asia Feb 2, 2018 Life Science
Regenerative Medicine Company’s China Deal is ‘Dramatically Transformational’ Feb 2, 2018 Life Science
